Lidocaina Kabi (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the rapid influx of sodium ions that initiates an action potential. This stabilises the neuronal membrane and stops the transmission of pain signals, producing a reversible loss of sensation in the targeted area.

The dose of Lidocaina Kabi is determined by the prescribing clinician based on the intended procedure, patient weight, age, and overall health. Only a qualified healthcare professional should calculate and administer the appropriate amount.

Safety data for lidocaine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Lidocaine has a rapid onset and moderate duration, making it suitable for short‑ to medium‑length procedures. Compared with bupivacaine, which offers a longer duration but slower onset, lidocaine is preferred when quick recovery of sensation is desired. Its safety profile is well‑established, though toxicity thresholds differ among agents.

Lidocaina Kabi should be stored at controlled room temperature, away from direct sunlight and moisture. Keep the vial in its original packaging, protect it from freezing, and ensure the seal remains intact until use. Do not refrigerate unless specifically instructed by the manufacturer.

The product is supplied as a sterile injectable solution and may be administered epidurally, intramuscularly, or intravenously, depending on the clinical indication. Administration must be performed by a qualified healthcare professional using aseptic technique and appropriate dosing calculations.

Serious adverse events include central nervous system toxicity such as seizures, cardiovascular effects like arrhythmias or severe hypotension, and rare allergic reactions ranging from urticaria to anaphylaxis. Prompt recognition and supportive management are essential if these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid the product. It is also contraindicated in individuals with severe heart block, uncontrolled epilepsy, or significant hepatic impairment without careful medical supervision.